Diane Tseng

Summary

Publications

  1. pmc Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
    Diane Tseng
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 110:11103-8. 2013
  2. pmc Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease
    Diane Tseng
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, Stanford, CA 94305, USA
    Radiat Oncol 7:5. 2012
  3. pmc The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
    Stephen B Willingham
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 109:6662-7. 2012

Collaborators

  • Michael F Clarke
  • Edward E Graves
  • Jian Wang
  • Ash A Alizadeh
  • Siddhartha Jaiswal
  • Mark P Chao
  • Richard T Hoppe
  • Matt van de Rijn
  • Stephen B Willingham
  • Piero Dalerba
  • Justin D Cohen
  • Theresa A Storm
  • Tejaswitha J Naik
  • Ferenc A Scheeren
  • Humberto Contreras-Trujillo
  • Per √ėyvind Enger
  • Oihana Murillo
  • Gary K Steinberg
  • Adriane R Mosley
  • Robert K Chin
  • Patricia Lovelace
  • Seraina M Schmid
  • Andrew J Gentles
  • Gordon Li
  • Tal Raveh
  • Siddhartha S Mitra
  • Kipp Weiskopf
  • Irving L Weissman
  • Griffith R Harsh
  • Maddalena Adorno
  • Ravindra Majeti
  • Chad Tang
  • Jens Peter Volkmer
  • Nelson N H Teng
  • Mei Sze Chua
  • Pradeep Rajendran
  • Samuel K So
  • John B Sunwoo
  • Chris K Sun
  • Robin Martin
  • Debashis Sahoo
  • Adriel C Cha
  • Dongkyoon Kim
  • Anne Kathrin Volkmer
  • Badreddin Edris

Detail Information

Publications3

  1. pmc Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
    Diane Tseng
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 110:11103-8. 2013
    ..This response protected animals from tumor challenge. We conclude that anti-CD47 antibody treatment not only enables macrophage phagocytosis of cancer but also can initiate an antitumor cytotoxic T-cell immune response. ..
  2. pmc Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease
    Diane Tseng
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, Stanford, CA 94305, USA
    Radiat Oncol 7:5. 2012
    ..We hypothesized that quantitative PET parameters may have predictive value beyond that of traditional clinical factors such as the International Prognostic Score (IPS) among Hodgkin's disease (HD) patients...
  3. pmc The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
    Stephen B Willingham
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 109:6662-7. 2012
    ..CD47 is therefore a validated target for cancer therapies...